An observational study in Healthy Aging, Nutritional Status and Dietary Protein, sponsored by Fundació Eurecat. Completed at 1 site in Spain. Open to participants aged 50 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-27.
Sponsored by Fundació Eurecat · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 27 studies in Muscle Weakness with a site in Spain — 3 open to participants now, 5 under way, none of them phase 3. Muscle Weakness · Spain.
Among the 27 studies in Muscle Weakness with a site in Spain, this one is one of 2 that started in 2024, is one of 8 observational ones, and was the 25th registered.
478 studies on the registry are indexed under Muscle Weakness; 72 are open to participants now.
Browse Muscle Weakness studies →3 of the 27 studies in Muscle Weakness with a site in Spain are open now. Recruiting first, the newest first:
Inés Llamas-Ramos · Sites in Spain
Ages 18–70
Pharming Technologies B.V. · Sites in Spain, United States, Australia and 8 more countries
Ages 18+
University of Santiago de Compostela · Sites in Spain
Ages 18+
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 52 Muscle Weakness studies recruiting now, 25 (48%) set no upper age limit and 20 (38%) stop at 75 or younger; 5 take children under 18; 18 take healthy volunteers.
This study: 50 Years to 75 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
27 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 2 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 200 is above the median of 66 across 107 observational studies indexed under Muscle Weakness.
Median enrollment 60 across the 19 interventional studies, 50 across the 8 observational. Of the 19 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
6 of 27 have an industry lead sponsor. The 10 most frequent:
Fundació Eurecat is the lead sponsor of 21 studies on the registry; 5 are open to participants now.
Fundació Eurecat has 1 study filed under Muscle Weakness — fewer than ten, so there is no comparison to draw.
2 of the studies in Muscle Weakness with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07745712ABLE Human Motion S.L.Clinical Investigation to Validate the Safety and Performance of the ABLE Kids Device in Pediatric Patients With Neurological Gait Disorders in a Clinical Setting | 2026-12-31 |
| NCT05650229Pharming Technologies B.V.Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease | 2027-10 |
Add all 2 to your calendar (.ics) → With an account.
Among the 27 studies in Muscle Weakness with a site in Spain, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This multicenter, cross-sectional observational study aims to use precision nutrition tools to identify metabolic clusters in adults aged 50-75 years, enabling tailored nutritional and protein recommendations based on specific metabolic characteristics. Conducted at Eurecat-Reus (Catalonia) and AZTI (Bizkaia), the study will enroll 200 participants (75 at Eurecat, 125 at AZTI). Analyses will include metabolomics, gut microbiota profiling, epigenomics, and glycomics, with the goal of refining dietary guidelines and protein intake recommendations to address the specific needs of aging populations.
The study hypothesizes that metabolic characterization using precision nutrition tools in adults aged 50 to 75 will enable the identification of clusters with similar metabolic profiles, thereby enhancing our understanding of each group's nutritional needs and facilitating the development of tailored dietary recommendations, particularly regarding protein intake. This multicenter, cross-sectional observational study will recruit 200 participants, 75 at Eurecat-Reus (Catalonia) and 125 at AZTI (Bizkaia), and will integrate metabolic, clinical, anthropometric, lifestyle, dietary, and microbiota data to form these clusters. The primary objective is to establish metabolic profiles and clusters using precision nutrition tools, while secondary objectives include identifying biomarkers associated with health and aging, assessing the relationship between protein intake and metabolic health, and exploring the associations between gut microbiota composition, glycomic patterns, and metabolic status. Participants will attend two visits: an initial visit for eligibility confirmation and informed consent, followed by a second fasting visit for blood sampling, anthropometric measurements, collection of pre-obtained samples, and the administration of validated questionnaires on lifestyle, dietary intake, and physical activity. Ultimately, the integrated analysis of these data will refine nutritional recommendations to better address the specific metabolic needs of each cluster, thereby improving dietary guidance and overall metabolic health in the aging population.
The cohort of the proposed study consists of 200 adults aged 50 to 75 years, who are recruited from two different research centers (Eurecat and AZTI) in Spain.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Autoimmune disease
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
200 adults aged 50 to 75 years, who are recruited from two different research centers (Eurecat and AZTI) in Spain.
Identification of nutritional clusters based on metabolic and biomarker profiles
Development of group-based precision nutrition recommendations derived from metabotyping approaches, with special emphasis on protein requirements, by clustering individuals aged 50-75 according to metabolic variables, gut microbiota composition, and classical anthropometric, biochemical, and clinical biomarkers.
Time frame: At day 1
Determination of Protein Intake Requirements for Each Cluster
stablishing specific protein intake needs for each identified cluster to optimize nutritional recommendations tailored to the metabolic and physiological characteristics of the target population.
Time frame: At day 1
Epigenomic Profile Characterization of a Study Subcohort
Analysis of epigenetic modifications in a subset of participants to refine the precision nutrition algorithm by incorporating epigenomic influences on metabolism and nutrient utilization.
Time frame: At day 1
Glycomic Profile Characterization of a Study Subcohort
Examination of glycan composition and glycosylation patterns in a subset of participants to assess their role in metabolic health and further personalize the group-based nutrition strategy.
Time frame: At day 1
Validation of Group-Based Precision Nutrition Algorithm
Integration of metabolic, microbiota, and biomarker-based clustering with epigenomic and glycomic data to improve the accuracy of the group-based precision nutrition algorithm.
Time frame: At day 1
Plan to share: No
Ran from Jul 2024 to primary completion in Jan 2025, 6 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fundació Eurecat